| Literature DB >> 27338584 |
Zhe Wen1, Huiying Liang2, Jiankun Liang1, Qifeng Liang1, Huimin Xia3.
Abstract
INTRODUCTION: Laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy is gaining popularity as a treatment for choledochal cyst (CDC) in children. However, the learning curve for this challenging laparoscopic procedure has not been addressed. The aim of this study is to determine the characteristics of the learning curve of this procedure. This may guide the training in institutions currently not using this technique.Entities:
Keywords: Choledochal cyst; Laparoscopy; Learning curve
Mesh:
Year: 2016 PMID: 27338584 PMCID: PMC5266761 DOI: 10.1007/s00464-016-5032-5
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Characteristics stratified by the completion of the learning curve (CLC) cutoff
| Variables | Total ( | CLC cutoff |
|
| |
|---|---|---|---|---|---|
| Group A ( | Group B ( | ||||
|
| |||||
| Sex, no. (%) | |||||
| Male | 18/104 (17.3) | 7/37 (18.9) | 11/67 (16.4) | 0.10 | 0.75 |
| Female | 86/104 (82.7) | 30/37 (81.1) | 56/67 (83.6) | ||
| Age, mean (SD), months | 35.9 (24.3) | 40.7 (26.1) | 33.2 (23.0) | 1.52 | 0.13 |
| Comorbidity, no. (%) | |||||
| None | 101/104 (97.1) | 37/37 (100) | 64/67 (95.5) | –a | 0.55 |
| One or more | 3/104 (2.9) | 0/37 (0) | 3/67 (4.5) | ||
| Disease duration, mean (SD), days | 226.8 (345.2) | 291.8 (449.1) | 190.9 (268.8) | 2.06 | 0.16 |
| Type of cyst, no. (%) | |||||
| 1a | 64/104 (61.5) | 23/37 (62.2) | 41/67 (61.2) | ||
| 1c | 25/104 (24.0) | 8/37 (21.6) | 17/67 (25.4) | 0.27 | 0.87 |
| 4a | 15/104 (14.4) | 6/37 (16.2) | 9/67 (13.4) | ||
| Size of cyst, mean (SD), cm | 3.4 (3.0) | 3.3 (2.1) | 3.4 (3.4) | 0.09 | 0.93 |
| Abdominal pain, no. (%) | |||||
| No | 28/104 (26.9) | 7/37 (18.9) | 21/67 (31.3) | 1.87 | 0.17 |
| Yes | 76/104 (73.1) | 30/37 (81.1) | 46/67 (68.7) | ||
| Jaundice, no. (%) | |||||
| No | 75/104 (72.1) | 30/37 (81.1) | 45/67 (67.2) | 2.30 | 0.13 |
| Yes | 29/104 (27.9) | 7/37 (18.9) | 22/67 (32.8) | ||
| Jaundice subsided, no. (%) | |||||
| No | 13/104 (12.5) | 4/37 (10.8) | 9/67 (13.4) | 0.15 | 0.70 |
| Yes | 91/104 (87.5) | 33/37 (89.2) | 58/67 (86.6) | ||
|
| |||||
| Operation time, mean (SD), min | 278.5 (81.7) | 352.2 (80.5) | 240.5 (50.6) | 8.37 | <0.001 |
| Excision time, mean (SD), min | 117.6 (47.7) | 144.8 (60.4) | 102.4 (29.9) | 4.77 | <0.001 |
| Anastomosis time, mean (SD), min | 50.9 (27.2) | 74.1 (29.6) | 38.0 (14.2) | 8.36 | <0.001 |
| Blood loss, mean (SD), ml | 12.0 (18.9) | 14.2 (18.0) | 10.7 (19.4) | 0.88 | 0.38 |
| Adhesion score, no. (%) | |||||
| Low | 48/104 (46.2) | 17/37 (45.9) | 31/67 (46.3) | 2.50 | 0.29 |
| Middle | 23/104 (22.1) | 11/37 (29.7) | 12/67 (17.9) | ||
| High | 33/104 (31.7) | 9/37 (24.3) | 24/67 (35.8) | ||
| Transfusion, no. (%) | |||||
| No | 100/104 (96.2) | 34/37 (91.9) | 66/67 (98.5) | –a | 0.13 |
| Yes | 4/104 (3.8) | 3/37 (8.1) | 1/67 (1.5) | ||
| Conversions, no. (%) | |||||
| No | 97/104 (93.3) | 33/37 (89.2) | 64/67 (95.5) | –a | 0.24 |
| Yes | 7/104 (6.7) | 4/37 (10.8) | 3/67 (4.5) | ||
|
| |||||
| Hospital stay, mean (SD), days | 8.4 (3.1) | 9.4 (3.8) | 7.8 (2.5) | 2.52 | 0.01 |
| Complications, no. (%) | |||||
| No | 98/104 (94.2) | 32/37 (86.5) | 66/67 (98.5) | –a | 0.02 |
| Yes | 6/104 (5.8) | 5/37 (13.5) | 1/67 (1.5) | ||
CLC completion of the learning curve
aFisher’s exact test
Fig. 1Learning curve of the first 104 consecutive laparoscopic choledochal cyst excision and Roux-en-Y hepaticojejunostomy pediatric cases. Note A Correlation between the length of the operation and the sequence of the procedures performed, B cumulative sum (CUSUM) plot for the overall surgical time, C excision time, and D anastomosis time
Multifactorial analysis of factors associated with logarithm of the length of operation
| Variables |
| SE | OR | 95 % CI |
|
|---|---|---|---|---|---|
|
| |||||
| Sex (male vs. female) | 0.04 | 0.05 | 1.04 | 0.96–1.14 | 0.35 |
| Age (for each month) | 9.87 × 10−5 | 0.001 | 1.00 | 0.99–1.00 | 0.92 |
| Comorbidities (yes vs. no) | 0.24 | 0.17 | 1.27 | 0.91–1.77 | 0.16 |
| Disease duration (vs. ≤30 days) | |||||
| 1–6 months | −0.05 | 0.08 | 0.95 | 0.81–1.11 | 0.50 |
| >6 months | −0.07 | 0.07 | 0.94 | 0.82–1.08 | 0.36 |
| Type of cyst (vs. 1a) | |||||
| 1c | −0.05 | 0.04 | 0.95 | 0.87–1.04 | 0.24 |
| 4a | −0.04 | 0.05 | 0.96 | 0.86–1.07 | 0.42 |
| Size of cyst (for each cm) | 0.001 | 0.006 | 1.00 | 0.99–1.00 | 0.85 |
| Abdominal pain (yes vs. no) | −0.01 | 0.05 | 0.99 | 0.90–1.09 | 0.81 |
| Jaundice (yes vs. no) | 0.05 | 0.05 | 1.05 | 0.95–1.15 | 0.34 |
| Jaundice subsided (yes vs. no) | −0.11 | 0.07 | 0.90 | 0.79–1.03 | 0.12 |
| CLC (group B vs. group A) | −0.39 | 0.04 | 0.68 | 0.63–0.73 | <0.001 |
|
| |||||
| Adhesions score (vs. low) | |||||
| Middle | 0.23 | 0.07 | 1.25 | 1.08–1.45 | 0.002 |
| High | 0.33 | 0.08 | 1.40 | 1.20–1.62 | <0.001 |
Fig. 2Comparison of the means of disease duration (days) in different levels of adhesion. Note A group A and B group B
Characteristics of the patients converted to open surgery
| No. | Group | Sex | Age (months) | Symptom | Reasons for conversion |
|---|---|---|---|---|---|
| 1 | 1 | F | 132 | Pain with jaundice | Dense adhesion |
| 2 | 1 | F | 17 | Asymptomatic | Dense adhesion |
| 3 | 1 | F | 29 | Jaundice | Loop rotation |
| 4 | 1 | F | 25 | Pain | Hepatic duct stenosis |
| 5 | 2 | F | 36 | Pain | Accessory hepatic duct |
| 6 | 2 | F | 48 | Pain | Dense adhesion and capillary hemorrhage |
| 7 | 2 | F | 84 | Pain | Accompanied with paraduodenal hernia |
Characteristics of the patients with postoperative complications
| No. | Group | Sex | Age (months) | Symptom | Complication | Treatment |
|---|---|---|---|---|---|---|
| 1 | 1 | F | 72 | Abdominal pain | Bile leakage | Re-laparotomy and re-anastomosis |
| 2 | 1 | F | 36 | Abdominal pain | Pancreatic leakage | Conservative treatment for 2 weeks |
| 3 | 1 | F | 32 | Jaundice | Bile leakage | Conservative treatment for 2 weeks |
| 4 | 1 | M | 30 | Abdominal pain | Abdominal fluid collection | Conservative treatment |
| 5 | 1 | F | 28 | Pain and jaundice | Hemoperitoneum | Re-laparotomy |
| 6 | 2 | F | 5 | Jaundice | Chyloperitoneum | Conservative for 38 days |
Factors influencing the postoperative adverse outcomes
| Variables |
| SE | OR | 95 % CI |
|
|---|---|---|---|---|---|
|
| |||||
| Sex (male vs. female) | −1.22 | 1.08 | 0.29 | 0.04–2.44 | 0.26 |
| Age (for each month) | 0.003 | 0.02 | 1.00 | 0.97–1.03 | 0.83 |
| Comorbidities (yes vs. no) | 3.42 | 1.47 | 30.65 | 1.71–549.63 | 0.02 |
| Disease duration (vs. ≤ 30 days) | |||||
| 1–6 months | 0.93 | 1.37 | 2.53 | 0.17–37.35 | 0.50 |
| >6 months | −0.79 | 1.70 | 0.45 | 0.02–12.69 | 0.64 |
| Type of cyst (vs. 1a) | |||||
| 1c | 0.73 | 0.87 | 2.07 | 0.37–11.47 | 0.41 |
| 4a | −0.64 | 0.98 | 0.53 | 0.08–3.57 | 0.51 |
| Size of cyst (for each cm) | −0.01 | 0.14 | 0.99 | 0.76–1.29 | 0.92 |
| Abdominal pain (yes vs. no) | −0.72 | 0.87 | 0.49 | 0.09–2.71 | 0.41 |
| Jaundice (yes vs. no) | 0.72 | 1.04 | 2.06 | 0.27–15.78 | 0.49 |
| Jaundice subsided (yes vs. no) | −0.92 | 1.39 | 0.40 | 0.03–6.09 | 0.51 |
| CLC (group B vs. group A) | −2.64 | 0.79 | 0.07 | 0.02–0.34 | 0.001 |
|
| |||||
| Dense adhesions (vs. low) | |||||
| Middle | −0.07 | 1.52 | 0.93 | 0.05–18.32 | 0.96 |
| High | 0.69 | 1.41 | 1.99 | 0.13–31.53 | 0.63 |
Characteristics associated with logarithm of the length of postoperative hospital stay
| Variables |
| SE | OR | 95 % CI |
|
|---|---|---|---|---|---|
|
| |||||
| Sex (male vs. female) | −0.10 | 0.09 | 0.90 | 0.76–1.07 | 0.25 |
| Age (for each month) | −0.001 | 0.002 | 1.00 | 0.98–1.03 | 0.42 |
| Comorbidities (yes vs. no) | 0.80 | 0.19 | 2.23 | 1.55–3.21 | <0.001 |
| Disease duration (vs. ≤30 days) | |||||
| 1–6 months | −0.23 | 0.15 | 0.80 | 0.59–1.07 | 0.13 |
| >6 months | −0.02 | 0.13 | 0.98 | 0.75–1.27 | 0.88 |
| Type of cyst (vs. 1a) | |||||
| 1c | −0.08 | 0.08 | 0.92 | 0.78–1.09 | 0.33 |
| 4a | −0.18 | 0.09 | 0.84 | 0.70–1.00 | 0.06 |
| Size of cyst (for each cm) | 0.002 | 0.01 | 1.00 | 0.98–1.03 | 0.84 |
| Abdominal pain (yes vs. no) | 0.05 | 0.09 | 1.05 | 0.89–1.25 | 0.56 |
| Jaundice (yes vs. no) | 0.21 | 0.07 | 1.23 | 1.07–1.43 | 0.005 |
| Jaundice subsided (yes vs. no) | 0.17 | 0.12 | 1.19 | 0.93–1.50 | 0.16 |
| CLC (group B vs. group A) | −0.15 | 0.07 | 0.86 | 0.76–0.98 | 0.03 |
|
| |||||
| Dense adhesions (vs. low) | |||||
| Middle | 0.17 | 0.14 | 1.19 | 0.90–1.57 | 0.22 |
| High | −0.05 | 0.14 | 0.95 | 0.73–1.26 | 0.74 |
|
| |||||
| Adverse outcomes (yes vs. no) | 0.28 | 0.09 | 1.33 | 1.11–1.59 | 0.002 |